130 related articles for article (PubMed ID: 8836790)
1. Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
Yaman O; Baltaci S; Arikan N; Ozdiler E; Göğüş O; Müftüoğlu YZ
Int Urol Nephrol; 1996; 28(2):207-10. PubMed ID: 8836790
[TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
[TBL] [Abstract][Full Text] [Related]
3. Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
Takashi M; Sakata T; Kato K
Jpn J Cancer Res; 1993 Mar; 84(3):304-9. PubMed ID: 8486529
[TBL] [Abstract][Full Text] [Related]
4. Clinical biochemistry of neuron specific enolase.
Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Takashi M; Haimoto H; Tanaka J; Murase T; Kato K
J Urol; 1989 Apr; 141(4):830-4. PubMed ID: 2648028
[TBL] [Abstract][Full Text] [Related]
6. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Rasmuson T; Grankvist K; Roos G; Ljungberg B
Acta Oncol; 1999; 38(5):623-8. PubMed ID: 10427952
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
9. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
D'Alessandro M; Mariani P; Lomanto D; Carlei F; Lezoche E; Speranza V
Tumour Biol; 1992; 13(5-6):352-7. PubMed ID: 1290031
[TBL] [Abstract][Full Text] [Related]
10. Serum gamma-enolase and prognosis of patients with renal cell carcinoma.
Rasmuson T; Grankvist K; Ljungberg B
Cancer; 1993 Aug; 72(4):1324-8. PubMed ID: 8339221
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase--a serum tumour marker in seminoma?
Fosså SD; Klepp O; Paus E
Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of renal cell carcinoma by anti neuron specific enolase (NSE) antibody].
Senga Y; Satomi Y; Fukuda M; Ebato T; Nakahashi M; Hosaka M; Tanaka Y; Misugi K
Nihon Hinyokika Gakkai Zasshi; 1988 Nov; 79(11):1818-23. PubMed ID: 3216564
[No Abstract] [Full Text] [Related]
13. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
Oishi S; Sato T
Cancer; 1988 Mar; 61(6):1167-70. PubMed ID: 3342373
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
Wibe E; Hannisdal E; Paus E; Aamdal S
Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
[TBL] [Abstract][Full Text] [Related]
16. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
17. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
[TBL] [Abstract][Full Text] [Related]
19. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Huang Z; Xu D; Zhang F; Ying Y; Song L
Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
[TBL] [Abstract][Full Text] [Related]
20. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
